Literature DB >> 5077924

Immunosuppression by co-trimoxazole.

H Arvilommi, M Vuori, A Salmi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5077924      PMCID: PMC1788659          DOI: 10.1136/bmj.3.5829.761-b

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells.

Authors:  A B STAVITSKY
Journal:  J Immunol       Date:  1954-05       Impact factor: 5.422

2.  Immunosuppressive powers of the antibacterial agent trimethoprim.

Authors:  M W Ghilchik; A S Morris; D S Reeves
Journal:  Nature       Date:  1970-07-25       Impact factor: 49.962

3.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05
  3 in total
  6 in total

1.  In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.

Authors:  A Dhondt; R Vanholder; M A Waterloos; G Glorieux; R De Smet; S Ringoir
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

2.  Antibiotics and suppression of lymphocyte function in vitro.

Authors:  G Banck; A Forsgren
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

3.  Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functions in vitro: in vivo effects of co-trimoxazole.

Authors:  R Anderson; G Grabow; R Oosthuizen; A Theron; A J Van Rensburg
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

4.  Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).

Authors:  Y Kobayashi; D Amano; K Ueda; Y Kagosaki; T Usui
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

5.  Effect of oral proguanil on human lymphocyte proliferation.

Authors:  I C Bygbjerg; H Flachs
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; P C McNabb; T D Makres; S Feldman
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.